Cohort study evaluates dietary intake and hepatic choline levels in healthy women, indicating MRS may serve as a biomarker.
Background: Non-invasive biomarkers of liver metabolism are essential for early detection of metabolic alterations. Choline plays a central role in hepatic function, yet its dietary intake and imaging correlates remain underexplored. This study evaluated the feasibility of proton Magnetic Resonance Spectroscopy (1H-MRS) at 3T for hepatic choline quantification and examined its correlation with dietary intake in young women, a population at risk of nutrient-sensitive liver conditions. Methods: In this prospective cohort study, 88 healthy female radiology students (mean age: 21.4 ± 1.8 years) underwent single-voxel 1H-MRS of the liver using a 3T Siemens Magnetom Vida scanner. Spectra were acquired with a point-resolved spectroscopy (PRESS) sequence (TR = 2000 ms, TE = 40 ms, voxel size = 20 × 20 × 20 mm3), with automated shimming and unsuppressed water referencing. Spectral analysis was performed using LCModel (v6.3), applying quality thresholds (Signal-to-Noise Ratio (SNR) > 5, linewidth < 0.1 ppm, Cramér–Rao Lower Bound (CRLB) < 20%. Hepatic choline concentrations were expressed in Institutional Units (IU). Dietary intake was assessed using a validated Food Frequency Questionnaire (FFQ). Results: High-quality spectra were consistently obtained (mean SNR: 12.6 ± 3.1; linewidth: 0.048 ± 0.012 ppm). Mean hepatic choline concentration was 4.63 ± 1.21 IU, while mean dietary intake was 29.1 ± 8.7 mg/day. A significant positive correlation was observed (r = 0.555, p < 0.001). Regression analysis confirmed dietary intake as a significant predictor (β = 0.56, R2 = 0.308, p < 0.001). Conclusion: 1H-MRS at 3T is a feasible and reproducible technique for hepatic choline quantification. By measuring metabolites directly in the liver at their site of production, rather than in circulation, where concentrations may be altered, MRS provides physiologically relevant insights into nutrient-related hepatic metabolism. Its correlation with dietary intake highlights its potential as a translational imaging biomarker for early detection and risk stratification of nutrient-sensitive liver conditions.
No takes yet. Share an insight, caveat, or question.
Hawesa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: